論文・技術情報追加のお知らせ

①Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System.

COVID-19患者におけるレムデシビル関連急性腎障害のシグナル調査研究

対象DB：FAERS

②Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis.

妊娠中におけるCOVID-19ワクチン接種の安全性調査研究

対象DB：VAERS

③Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study.

CAR-T製剤の心毒性リスク調査研究

対象DB：FAERS

④Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System.

ベイジアン理論を用いたデータマイニングによる新規抗悪性腫瘍剤に関連する消化管穿孔のシグナル探索研究

対象DB：FAERS

⑤Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease.

フィブラート系薬剤の腎リスク評価研究

対象DB：FAERS

⑥Neurotoxicity induced by taxane-derived drugs: Analysis of the FAERS Database 2017-2021.

神経系有害事象とタキサン系薬剤との関連性評価研究

対象DB：FAERS

⑦Characteristics and completeness of spontaneous reports by reporter's role in Germany: An analysis of the EudraVigilance database using the example of opioid-associated abuse, dependence, or withdrawal.

オピオイドに関連する自発的な報告における、報告者別の完全性、特徴についての分析研究

対象DB：EudraVigilance